Cohen & Steers' (CNS) CEO Robert Steers on Q2 2015 Results - Earnings Call Transcript

Jul. 16, 2015 1:57 PM ETCohen & Steers, Inc. (CNS) Stock
SA Transcripts profile picture
SA Transcripts
150.88K Followers

Q2: 2015-07-15 Earnings Summary

EPS of $0.45 beats by $0.06 | Revenue of $83.50M (6.49% Y/Y) beats by $2.50M

Cohen & Steers, Inc. (NYSE:CNS) Q2 2015 Earnings Conference Call July 16, 2015 11:00 AM ET

Executives

Adam Johnson - SVP and Associate General Counsel
Matthew Stadler - CFO
Robert Steers - CEO
Joseph Harvey - President and Chief Investment Officer

Analysts

Adam Beatty - Bank of America Merrill Lynch
Mac Sykes - Gabelli & Company

Operator

Ladies and gentlemen, thank you for standing by and welcome to the Cohen & Steers' Second Quarter 2015 Financial Results Conference Call. During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question-and-answer session. [Operator Instructions] As a reminder, this conference is being recorded Thursday, July 16, 2015, and I would now like to turn the conference over to Mr. Adam Johnson, Senior Vice President and Associate General Counsel. Please go ahead, sir.

Adam Johnson

Thank you and welcome to the Cohen & Steers' second quarter 2015 earnings conference call. Joining me are Chief Executive Officer, Bob Steers; Executive Chairman, Marty Cohen; our President, Joe Harvey; and our Chief Financial Officer, Matt Stadler.

Before I turn the call over to Matt, I want to point out that during the course of this conference call we may make a number of forward-looking statements. These forward-looking statements are subject to various risks and uncertainties and there are important factors that could cause actual outcomes to differ materially from those indicated in these statements.

We believe that some of these factors are described in the Risk Factors section of our 2014 Form 10-K, which is available on our Web-site at cohenandsteers.com. I want to remind you that the Company assumes no duty to update any forward-looking statements.

Also, the presentation we make today may contain pro forma or non-GAAP financial measures, which we believe are meaningful in evaluating the Company's performance. For disclosures

Recommended For You

About CNS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on CNS